Is this really so? Couldn't this constitute another approved generic in the context of lowering MNTAs royalty rate? Or would the sole approved generic designation apply to each of the specific product formulations?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.